To explore the mechanism of resistance to head and neck squamous cell cancer (HNSCC) radiotherapy, Chen et al3 analyzed the DNA methylation of cyclin D2 (CCND2) in 2 counterpart HNSCC cell lines. Here, CCND2 is linked to head and neck squamous cell carcinoma.